Exact Mass: 597.4427

Exact Mass Matches: 597.4427

Found 140 metabolites which its exact mass value is equals to given mass value 597.4427, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cer(d16:1/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(5Z,7Z,10Z,13Z,16Z,19Z)-N-[(2S,3R,4E)-1,3-dihydroxyhexadec-4-en-2-yl]-4-hydroxydocosa-5,7,10,13,16,19-hexaenamide

C38H63NO4 (597.4757)


Cer(d16:1/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d16:1/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(4Z,8Z,10Z,13Z,16Z,19Z)-N-[(2S,3R,4E)-1,3-dihydroxyhexadec-4-en-2-yl]-7-hydroxydocosa-4,8,10,13,16,19-hexaenamide

C38H63NO4 (597.4757)


Cer(d16:1/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d16:1/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(4Z,7Z,10Z,12E,16Z,19Z)-N-[(2S,3R,4E)-1,3-dihydroxyhexadec-4-en-2-yl]-14-hydroxydocosa-4,7,10,12,16,19-hexaenamide

C38H63NO4 (597.4757)


Cer(d16:1/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d16:1/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(4Z,7Z,10Z,13E,15E,19Z)-N-[(2S,3R,4E)-1,3-dihydroxyhexadec-4-en-2-yl]-17-hydroxydocosa-4,7,10,13,15,19-hexaenamide

C38H63NO4 (597.4757)


Cer(d16:1/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d16:1/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(4Z,7Z,10Z,13Z)-N-[(2S,3R,4E)-1,3-dihydroxyhexadec-4-en-2-yl]-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenamide

C38H63NO4 (597.4757)


Cer(d16:1/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d18:2(4E,14Z)/20:4(6E,8Z,11Z,14Z)+=O(5))

(6E,8Z,11Z,14Z)-N-[(2S,3R,4E,14Z)-1,3-dihydroxyoctadeca-4,14-dien-2-yl]-5-oxoicosa-6,8,11,14-tetraenamide

C38H63NO4 (597.4757)


Cer(d18:2(4E,14Z)/20:4(6E,8Z,11Z,14Z)+=O(5)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d18:2(4E,14Z)/20:4(5Z,8Z,11Z,13E)+=O(15))

(5Z,8Z,11Z,13E)-N-[(2S,3R,4E,14Z)-1,3-dihydroxyoctadeca-4,14-dien-2-yl]-15-oxoicosa-5,8,11,13-tetraenamide

C38H63NO4 (597.4757)


Cer(d18:2(4E,14Z)/20:4(5Z,8Z,11Z,13E)+=O(15)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(5Z,8Z,11Z,14Z,16E,18R)-N-[(2S,3R,4E,14Z)-1,3-dihydroxyoctadeca-4,14-dien-2-yl]-18-hydroxyicosa-5,8,11,14,16-pentaenamide

C38H63NO4 (597.4757)


Cer(d18:2(4E,14Z)/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(5Z,8Z,11Z,13E,17Z)-N-[(2S,3R,4E,14Z)-1,3-dihydroxyoctadeca-4,14-dien-2-yl]-16-hydroxyicosa-5,8,11,13,17-pentaenamide

C38H63NO4 (597.4757)


Cer(d18:2(4E,14Z)/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(5Z,8Z,10E,14Z,17Z)-N-[(2S,3R,4E,14Z)-1,3-dihydroxyoctadeca-4,14-dien-2-yl]-12-hydroxyicosa-5,8,10,14,17-pentaenamide

C38H63NO4 (597.4757)


Cer(d18:2(4E,14Z)/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Cer(d18:2(4E,14Z)/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(6E,8Z,11Z,14Z,17Z)-N-[(2S,3R,4E,14Z)-1,3-dihydroxyoctadeca-4,14-dien-2-yl]-5-hydroxyicosa-6,8,11,14,17-pentaenamide

C38H63NO4 (597.4757)


Cer(d18:2(4E,14Z)/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) is an oxidized ceramide (Cer). As all ceramides, oxidized ceramides are members of the class of compounds known as sphingolipids (SPs), or glycosylceramides. SPs are lipids containing a backbone of sphingoid bases (e.g. sphingosine or sphinganine) that are often covalently bound to a fatty acid derivative through N-acylation. SPs are found in cell membranes, particularly in peripheral nerve cells and the cells found in the central nervous system (including the brain and spinal cord). Sphingolipids are extremely versatile molecules that have functions controlling fundamental cellular processes such as cell division, differentiation, and cell death. Impairments associated with sphingolipid metabolism are associated with many common human diseases such as diabetes, various cancers, microbial infections, diseases of the cardiovascular and respiratory systems, Alzheimer’s disease and other neurological syndromes. The biosynthesis and catabolism of sphingolipids involves a large number of intermediate metabolites where many different enzymes are involved. Simple sphingolipids, which include the sphingoid bases and ceramides, make up the early products of the sphingolipid synthetic pathways, while complex sphingolipids may be formed by the addition of head groups to the ceramide template (Wikipedia). In humans, ceramides are phosphorylated to ceramide phosphates (CerPs) through the action of a specific ceramide kinase (CerK). Ceramide phosphates are important metabolites of ceramides as they act as a mediators of the inflammatory response. Ceramides are also one of the hydrolysis byproducts of sphingomyelins (SMs) through the action of the enzyme sphingomyelin phosphodiesterase, which has been identified in the subcellular fractions of human epidermis (PMID: 25935) and many other tissues. Ceramides can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID: 14998372). Ceramides are key in the biosynthesis of glycosphingolipids and gangliosides. In terms of its appearance and structure, Cer(d18:1/22:1(13Z)) is a colorless solid that consists of an unsaturated 18-carbon sphingoid base with an attached unsaturated 13Z-docosenoyl fatty acid side chain. In most mammalian SPs, the 18-carbon sphingoid bases are predominant (PMID: 9759481).

   

Didemniserinolipid A

Didemniserinolipid A

C33H59NO8 (597.424)


   

Ala Arg Pro Lys Leu

Ala Arg Pro Lys Leu

C27H51N9O6 (597.3962)


   

LPS O-23:0;O

1-(2-methoxy-docosanyl)-sn-glycero-3-phosphoserine

C29H60NO9P (597.4005)


   

SCANDIUM(III) TRIS(2 2 6 6-TETRAMETHYL-&

SCANDIUM(III) TRIS(2 2 6 6-TETRAMETHYL-&

C33H60O6Sc (597.3949)


   

Rapacuronium

Rapacuronium

C37H61N2O4+ (597.4631)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents

   

Cer(d16:1/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

Cer(d16:1/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C38H63NO4 (597.4757)


   

Cer(d16:1/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

Cer(d16:1/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C38H63NO4 (597.4757)


   

Cer(d16:1/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

Cer(d16:1/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C38H63NO4 (597.4757)


   

Cer(d16:1/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

Cer(d16:1/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C38H63NO4 (597.4757)


   

Cer(d16:1/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

Cer(d16:1/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C38H63NO4 (597.4757)


   

Cer(d18:2(4E,14Z)/20:4(6E,8Z,11Z,14Z)+=O(5))

Cer(d18:2(4E,14Z)/20:4(6E,8Z,11Z,14Z)+=O(5))

C38H63NO4 (597.4757)


   

Cer(d18:2(4E,14Z)/20:4(5Z,8Z,11Z,13E)+=O(15))

Cer(d18:2(4E,14Z)/20:4(5Z,8Z,11Z,13E)+=O(15))

C38H63NO4 (597.4757)


   

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C38H63NO4 (597.4757)


   

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C38H63NO4 (597.4757)


   

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

Cer(d18:2(4E,14Z)/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C38H63NO4 (597.4757)


   

Cer(d18:2(4E,14Z)/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

Cer(d18:2(4E,14Z)/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C38H63NO4 (597.4757)


   

Jeffamine M-600

Jeffamine M-600

C30H63NO10 (597.4452)


   

O-(2-aminopropyl)-O-(2-methyoxyethyl)octa(propylene glycol)

O-(2-aminopropyl)-O-(2-methyoxyethyl)octa(propylene glycol)

C30H63NO10 (597.4452)


   
   

HexCer 20:3;2O/7:0

HexCer 20:3;2O/7:0

C33H59NO8 (597.424)


   

HexCer 24:3;2O/3:0

HexCer 24:3;2O/3:0

C33H59NO8 (597.424)


   

HexCer 8:1;2O/19:2

HexCer 8:1;2O/19:2

C33H59NO8 (597.424)


   

HexCer 18:3;2O/9:0

HexCer 18:3;2O/9:0

C33H59NO8 (597.424)


   

HexCer 9:0;2O/18:3

HexCer 9:0;2O/18:3

C33H59NO8 (597.424)


   

HexCer 19:3;2O/8:0

HexCer 19:3;2O/8:0

C33H59NO8 (597.424)


   

HexCer 9:1;2O/18:2

HexCer 9:1;2O/18:2

C33H59NO8 (597.424)


   

HexCer 22:3;2O/5:0

HexCer 22:3;2O/5:0

C33H59NO8 (597.424)


   

HexCer 25:3;2O/2:0

HexCer 25:3;2O/2:0

C33H59NO8 (597.424)


   

HexCer 23:3;2O/4:0

HexCer 23:3;2O/4:0

C33H59NO8 (597.424)


   

HexCer 21:3;2O/6:0

HexCer 21:3;2O/6:0

C33H59NO8 (597.424)


   

NAGly 16:4/19:2

NAGly 16:4/19:2

C37H59NO5 (597.4393)


   

NAGly 22:5/13:1

NAGly 22:5/13:1

C37H59NO5 (597.4393)


   

NAGly 18:5/17:1

NAGly 18:5/17:1

C37H59NO5 (597.4393)


   

NAGly 20:5/15:1

NAGly 20:5/15:1

C37H59NO5 (597.4393)


   

NAGly 13:1/22:5

NAGly 13:1/22:5

C37H59NO5 (597.4393)


   

NAGly 24:6/11:0

NAGly 24:6/11:0

C37H59NO5 (597.4393)


   

NAGly 22:6/13:0

NAGly 22:6/13:0

C37H59NO5 (597.4393)


   

NAGly 18:4/17:2

NAGly 18:4/17:2

C37H59NO5 (597.4393)


   

HexCer 17:3;2O/10:0

HexCer 17:3;2O/10:0

C33H59NO8 (597.424)


   

HexCer 11:1;2O/16:2

HexCer 11:1;2O/16:2

C33H59NO8 (597.424)


   

HexCer 14:2;2O/13:1

HexCer 14:2;2O/13:1

C33H59NO8 (597.424)


   

HexCer 12:2;2O/15:1

HexCer 12:2;2O/15:1

C33H59NO8 (597.424)


   

HexCer 11:0;2O/16:3

HexCer 11:0;2O/16:3

C33H59NO8 (597.424)


   

HexCer 13:2;2O/14:1

HexCer 13:2;2O/14:1

C33H59NO8 (597.424)


   

HexCer 16:3;2O/11:0

HexCer 16:3;2O/11:0

C33H59NO8 (597.424)


   

HexCer 10:1;2O/17:2

HexCer 10:1;2O/17:2

C33H59NO8 (597.424)


   

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]nonadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]nonadeca-4,8,12-triene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]octadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]octadeca-4,8,12-triene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]heptadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]heptadeca-4,8-diene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E)-3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]pentadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(10Z,12Z)-2-hydroxyoctadeca-10,12-dienoyl]amino]pentadeca-4,8-diene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E)-3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]trideca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(11Z,14Z)-2-hydroxyicosa-11,14-dienoyl]amino]trideca-4,8-diene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxyoctadec-11-enoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxynonadec-9-enoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid

C33H59NO6S (597.4063)


   

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]heptadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]heptadeca-4,8,12-triene-1-sulfonic acid

C33H59NO6S (597.4063)


   

2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyoctadecane-1-sulfonic acid

2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxyoctadecane-1-sulfonic acid

C34H63NO5S (597.4427)


   

(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]pentadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]pentadec-4-ene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-3-hydroxy-2-(octadecanoylamino)hexadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(octadecanoylamino)hexadeca-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxydodecane-1-sulfonic acid

2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxydodecane-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)nonadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(pentadecanoylamino)nonadeca-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)icosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(tetradecanoylamino)icosa-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

(E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydodec-4-ene-1-sulfonic acid

(E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxydodec-4-ene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-2-(decanoylamino)-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-(decanoylamino)-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]tetradec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]tetradec-4-ene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)henicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(tridecanoylamino)henicosa-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-3-hydroxy-2-(icosanoylamino)tetradeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(icosanoylamino)tetradeca-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-2-(hexadecanoylamino)-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-(hexadecanoylamino)-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]henicosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]henicosa-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyheptadec-4-ene-1-sulfonic acid

(E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxyheptadec-4-ene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxytrideca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxytrideca-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]hexadecane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]hexadecane-1-sulfonic acid

C34H63NO5S (597.4427)


   

(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]hexadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]hexadec-4-ene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]icosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]icosa-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxytridec-4-ene-1-sulfonic acid

(E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxytridec-4-ene-1-sulfonic acid

C34H63NO5S (597.4427)


   

3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]tetradecane-1-sulfonic acid

3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]tetradecane-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]pentadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]pentadeca-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-2-(heptadecanoylamino)-3-hydroxyheptadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-(heptadecanoylamino)-3-hydroxyheptadeca-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)tricosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(undecanoylamino)tricosa-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-(dodecanoylamino)-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]decane-1-sulfonic acid

3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]decane-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E,12E)-3-hydroxy-2-(nonadecanoylamino)pentadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-(nonadecanoylamino)pentadeca-4,8,12-triene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]hexadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]hexadeca-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]tetradeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]tetradeca-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]nonadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]nonadeca-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]dec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]dec-4-ene-1-sulfonic acid

C34H63NO5S (597.4427)


   

(4E,8E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxydodeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(Z)-docos-13-enoyl]amino]-3-hydroxydodeca-4,8-diene-1-sulfonic acid

C34H63NO5S (597.4427)


   

HexCer 14:3;2O/13:0

HexCer 14:3;2O/13:0

C33H59NO8 (597.424)


   

HexCer 15:3;2O/12:0

HexCer 15:3;2O/12:0

C33H59NO8 (597.424)


   

4-[2-[(Z)-heptadec-9-enoyl]oxy-3-heptanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(Z)-heptadec-9-enoyl]oxy-3-heptanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-[(Z)-henicos-11-enoyl]oxy-3-propanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(Z)-henicos-11-enoyl]oxy-3-propanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-[(Z)-nonadec-9-enoyl]oxy-3-pentanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(Z)-nonadec-9-enoyl]oxy-3-pentanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-butanoyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-butanoyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-acetyloxy-2-[(Z)-docos-13-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-acetyloxy-2-[(Z)-docos-13-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-hexanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-hexanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

(Z)-N-[(4E,8E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]tridec-8-enamide

(Z)-N-[(4E,8E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]tridec-8-enamide

C33H59NO8 (597.424)


   

(Z)-N-[(4E,8E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8-dien-2-yl]dodec-5-enamide

(Z)-N-[(4E,8E)-3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentadeca-4,8-dien-2-yl]dodec-5-enamide

C33H59NO8 (597.424)


   

4-[3-[(E)-tridec-8-enoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-tridec-8-enoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-decanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-decanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-[(E)-tridec-8-enoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-tridec-8-enoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-dodecanoyloxy-3-[(E)-dodec-5-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-dodecanoyloxy-3-[(E)-dodec-5-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-[(E)-dec-4-enoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-dec-4-enoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-tridecanoyloxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-tridecanoyloxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-[(E)-dec-4-enoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-dec-4-enoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-tridecanoyloxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-tridecanoyloxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[2-decanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-decanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

4-[3-dodecanoyloxy-2-[(E)-dodec-5-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-dodecanoyloxy-2-[(E)-dodec-5-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C34H63NO7 (597.4604)


   

2-[hydroxy-[3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium

C32H58N2O6P+ (597.4032)


   

2-[hydroxy-[(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C32H58N2O6P+ (597.4032)


   

2-[[(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H58N2O6P+ (597.4032)


   
   

DGTS 23:2;O

DGTS 23:2;O

C33H59NO8 (597.424)


   
   
   

CerP 15:0;O2/18:4

CerP 15:0;O2/18:4

C33H60NO6P (597.4158)


   

CerP 15:1;O2/18:3

CerP 15:1;O2/18:3

C33H60NO6P (597.4158)


   

CerP 15:2;O2/18:2

CerP 15:2;O2/18:2

C33H60NO6P (597.4158)


   

CerP 16:2;O2/17:2

CerP 16:2;O2/17:2

C33H60NO6P (597.4158)


   
   

ST 28:4;O;HexNAc

ST 28:4;O;HexNAc

C36H55NO6 (597.4029)


   
   

7-[2-(acetyloxy)-5-[15-(2-amino-3-hydroxypropoxy)pentadecyl]-6,8-dioxabicyclo[3.2.1]octan-7-yl]hept-2-enoic acid

7-[2-(acetyloxy)-5-[15-(2-amino-3-hydroxypropoxy)pentadecyl]-6,8-dioxabicyclo[3.2.1]octan-7-yl]hept-2-enoic acid

C33H59NO8 (597.424)